Drug developer Kamada Ltd. (TASE: KMDA) today announced that it has been included in the Deloitte Technology Fast 500 EMEA 2012. The list includes the 500 fastest-growing technology, media, telecommunications, life sciences, and cleantech companies in Europe, the Middle East, and Africa. The rankings are based on the five-year growth rate in 2007-11. Kamda had 311% growth in this period.
In Israel, on the basis of this index, Kamada is ranked among the top 15 growth companies. On December 15, the company joined the Tel Aviv Stock Exchange (TASE) Tel Aviv 100 Index.
Kamada CEO David Tsur said, "We are very proud to be included on Deloitte's prestigious list of the fastest growing companies in Europe, the Middle, and Africa. For an Israeli biopharmaceutical company, this achievement stands out even more, and we see ourselves as committed to continuing the momentum in sales. Our inclusion in this list is further international recognition of the company's business and scientific achievements."
Published by Globes [online], Israel business news - www.globes-online.com - on December 18, 2012
© Copyright of Globes Publisher Itonut (1983) Ltd. 2012